| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.3 | 7e-10 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |